Differences in Phage Recognition and Immunogenicity Contribute to Divergent Human Immune Responses to Escherichia Coli and Klebsiella Pneumoniae Phages

Overview

Journal Eur J Immunol

Specialty Allergy & Immunology

Date 2025 Mar 12

PMID 40071703

Authors

Huu Thanh Le

Carola Venturini

Alicia Fajardo Lubian

Bethany Bowring

Jonathan Iredell

Jacob George

Golo Ahlenstiel

Scott A Read

Affiliations

Soon will be listed here.

Abstract

Bacteriophages (phages) are emerging as a viable adjunct to antibiotics for the treatment of multidrug-resistant (MDR) bacterial infections. While intravenous phage therapy has proven successful in many cases, clinical outcomes remain uncertain due to a limited understanding of host response to phages. In this study, we conducted a comprehensive examination of the interaction between clinical-grade phages used to treat MDR Escherichia coli and Klebsiella pneumoniae infections, and human peripheral blood immune cells. Using whole transcriptome as well as proteomic approaches, we identified a strong inflammatory response to E. coli phage vB_EcoM-JIPh_Ec70 (herein, JIPh_Ec70) that was absent upon exposure to K. pneumoniae phage JIPh_Kp127. We confirmed that JIPh_Ec70's DNA recognition by the STING pathway was principally responsible for the activation of NF-kB and the subsequent inflammatory response. We further show that monocytes and neutrophils play a dominant role in phage uptake, primarily through complement-mediated phagocytosis. Significant differences in complement-mediated phagocytosis of JIPh_Kp127 and JIPh_Ec70 were observed, suggesting that reduced recognition, phagocytosis, and immunogenicity all contribute to the significantly decreased response to JIPh_Kp127. Our findings contribute to the progress of our understanding of the innate immune response to therapeutic phages and offer potential insights into how to improve the safety and effectiveness of phage therapy.

References

Miernikiewicz P, Dabrowska K, Piotrowicz A, Owczarek B, Wojas-Turek J, Kicielinska J . T4 phage and its head surface proteins do not stimulate inflammatory mediator production. PLoS One. 2013; 8(8):e71036. PMC: 3745418. DOI: 10.1371/journal.pone.0071036. View

Miernikiewicz P, Dabrowska K . Endocytosis of Bacteriophages. Curr Opin Virol. 2021; 52:229-235. DOI: 10.1016/j.coviro.2021.12.009. View

Kropinski A, Mazzocco A, Waddell T, Lingohr E, Johnson R . Enumeration of bacteriophages by double agar overlay plaque assay. Methods Mol Biol. 2008; 501:69-76. DOI: 10.1007/978-1-60327-164-6_7. View

Dabrowska K, Miernikiewicz P, Piotrowicz A, Hodyra K, Owczarek B, Lecion D . Immunogenicity studies of proteins forming the T4 phage head surface. J Virol. 2014; 88(21):12551-7. PMC: 4248953. DOI: 10.1128/JVI.02043-14. View

Kazmierczak Z, Majewska J, Milczarek M, Owczarek B, Dabrowska K . Circulation of Fluorescently Labelled Phage in a Murine Model. Viruses. 2021; 13(2). PMC: 7917791. DOI: 10.3390/v13020297. View

Klinman D, Takeshita F, Gursel I, Leifer C, Ishii K, Verthelyi D . CpG DNA: recognition by and activation of monocytes. Microbes Infect. 2002; 4(9):897-901. DOI: 10.1016/s1286-4579(02)01614-3. View

Bichet M, Chin W, Richards W, Lin Y, Avellaneda-Franco L, Hernandez C . Bacteriophage uptake by mammalian cell layers represents a potential sink that may impact phage therapy. iScience. 2021; 24(4):102287. PMC: 8024918. DOI: 10.1016/j.isci.2021.102287. View

Dlusskaya E, Atrazhev A, Ashbolt N . Colloid chemistry pitfall for flow cytometric enumeration of viruses in water. Water Res X. 2019; 2:100025. PMC: 6549941. DOI: 10.1016/j.wroa.2019.100025. View

Nishihara S, Kawasaki K . Enhanced cellular uptake of CpG DNA by α-helical antimicrobial peptide Kn2-7: Effects on macrophage responsiveness to CpG DNA. Biochem Biophys Res Commun. 2020; 530(1):100-106. DOI: 10.1016/j.bbrc.2020.07.013. View

10.

Khatami A, Lin R, Petrovic-Fabijan A, Alkalay-Oren S, Almuzam S, Britton P . Bacterial lysis, autophagy and innate immune responses during adjunctive phage therapy in a child. EMBO Mol Med. 2021; 13(9):e13936. PMC: 8422068. DOI: 10.15252/emmm.202113936. View

11.

Mandrup O, Lykkemark S, Kristensen P . Targeting of phage particles towards endothelial cells by antibodies selected through a multi-parameter selection strategy. Sci Rep. 2017; 7:42230. PMC: 5301479. DOI: 10.1038/srep42230. View

12.

Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T . Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell. 2006; 10(6):839-50. DOI: 10.1016/j.devcel.2006.04.002. View

13.

Lin Y, Chen Y, Fang C, Huang P, Liang S . Capsid proteins of foot-and-mouth disease virus interact with TLR2 and CD14 to induce cytokine production. Immunol Lett. 2020; 223:10-16. DOI: 10.1016/j.imlet.2020.04.008. View

14.

Sahu A, Kay B, Lambris J . Inhibition of human complement by a C3-binding peptide isolated from a phage-displayed random peptide library. J Immunol. 1996; 157(2):884-91. View

15.

Venturini C, Petrovic Fabijan A, Lubian A, Barbirz S, Iredell J . Biological foundations of successful bacteriophage therapy. EMBO Mol Med. 2022; 14(7):e12435. PMC: 9260219. DOI: 10.15252/emmm.202012435. View

16.

Aslam S, Lampley E, Wooten D, Karris M, Benson C, Strathdee S . Lessons Learned From the First 10 Consecutive Cases of Intravenous Bacteriophage Therapy to Treat Multidrug-Resistant Bacterial Infections at a Single Center in the United States. Open Forum Infect Dis. 2020; 7(9):ofaa389. PMC: 7519779. DOI: 10.1093/ofid/ofaa389. View

17.

Lehti T, Pajunen M, Skog M, Finne J . Internalization of a polysialic acid-binding Escherichia coli bacteriophage into eukaryotic neuroblastoma cells. Nat Commun. 2017; 8(1):1915. PMC: 5715158. DOI: 10.1038/s41467-017-02057-3. View

18.

Podlacha M, Gaffke L, Grabowski L, Mantej J, Grabski M, Pierzchalska M . Bacteriophage DNA induces an interrupted immune response during phage therapy in a chicken model. Nat Commun. 2024; 15(1):2274. PMC: 10937645. DOI: 10.1038/s41467-024-46555-7. View

19.

Gogokhia L, Buhrke K, Bell R, Hoffman B, Brown D, Hanke-Gogokhia C . Expansion of Bacteriophages Is Linked to Aggravated Intestinal Inflammation and Colitis. Cell Host Microbe. 2019; 25(2):285-299.e8. PMC: 6885004. DOI: 10.1016/j.chom.2019.01.008. View

20.

Lin H, Singla B, Ghoshal P, Faulkner J, Cherian-Shaw M, OConnor P . Identification of novel macropinocytosis inhibitors using a rational screen of Food and Drug Administration-approved drugs. Br J Pharmacol. 2018; 175(18):3640-3655. PMC: 6109223. DOI: 10.1111/bph.14429. View